Pharmacovigilance:
The Future Pharmaceutical Company is complying with the Egyptian Pharmacovigilance Authorities as well as the WHO.
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem. The goal of pharmacovigilance is the safer use of medicines, and this is usually achieved through the dissemination of accurate, timely, and clinically relevant information. Communicating the potential harm of drug use to physicians and patients is a matter of high priority, and Mepaco-Medifood will carry out the responsibility or dynamically participate in the process.
Our Goal:
Improve patient care and safety.
Improve public health.
Detect problems related to the use of medicines and communicate the findings in a timely manner.
To contribute to the assessment of the risk-benefit profile of the medicine, thus encouraging safer and more effective use of medicines.
Promote understanding and education in pharmacovigilance and its effective communication to the public.
The aim of ADR cards (adverse drug reactions):
Early detection of ADRs (adverse drug reactions)
Detection of an increased frequency of ADRs
Identification of predictors and possible mechanisms underlying ADRs.
Quantitative estimation of the risk-benefit profiles of drugs and dissemination of information needed to improve drug prescribing and regulation.
Prevention of preventable ADRs.
Encouraging the rational and safe use of drugs.